XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

Exercise price  $ 0.84-$5.00 
Expected dividend yield   0%
Risk free interest rate   4.01%-4.25%
Expected life in years   10 
Expected volatility   213-215%
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following is an analysis of the stock option grant activity under the Plan:

 

   Number  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Life

 
Stock Options               
Outstanding December 31, 2023   1,357,466   $7.39    4.49 
Granted   742,150    1.73    9.98 
Expired   (139,875)   5.94    - 
Exercised   -    -    - 
Outstanding March 31, 2024   1,959,741   $5.35    6.50 
SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES

A summary of the status of the Company’s nonvested options as of March 31, 2024, and changes during the three months ended March 31, 2024,   is presented below:

 

Nonvested Options  Options  

Weighted-Average

Exercise Price

 
Nonvested at December 31, 2023   49,832   $14.72 
Granted   742,150    1.73 
Vested   (16,961)   11.27 
Forfeited   -    - 
Nonvested at March 31, 2024   775,021   $2.36 
SUMMARY OF WARRANT

A summary of warrant issuances are as follows:

 

   Number  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Life

 
Warrants               
                
Outstanding December 31, 2023   942,566   $19.47    2.31 
Granted   -    -    - 
Expired   -    -    - 
Exercised   -    -    - 
Outstanding March 31, 2024   942,566   $19.47    2.06